PAX3 and neoplasm: When combined with LiCl and chloroquine, this multi-faceted regimen would inhibit the activity of PAX3-FOXO1 [36], promote the death of aneuploid cells, which is induced by the presence of the oncogenic fusion protein [20], and potentially reactivate the differentiation process, thereby attacking ARMS tumor cells on multiple different biological fronts.